Endoplasmic reticulum calcium pumps and cancer cell differentiation

Biomolecules

Volumn 2, Issue 1, 2012, Pages 165-186

  Papp, Béla ^a   Brouland, Jean Philippe ^b   Arbabian, Atousa ^c   Gélébart, Pascal ^d   Kovács, Tünde ^e   Bobe, Régis ^c   Enouf, Jocelyne ^c   Varin Blank, Nadine ^a   Apáti, Ágota ^f  

^a UNIVERSITÉ PARIS 13   (France)

^b HÔPITAL LARIBOISIÈRE   (France)

^c INSERM   (France)

^d UNIVERSITY OF ALBERTA   (Canada)

^e SEMMELWEIS UNIVERSITY   (Hungary)

^f INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

Author keywords

Calcium signalling; Cancer; Cell differentiation; Endoplasmic reticulum; SERCA

Indexed keywords

ADENOSINE TRIPHOSPHATASE (CALCIUM); APC PROTEIN; BETA CATENIN; CALCINEURIN; CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE; CALPAIN; EPSTEIN BARR VIRUS ANTIGEN 2; INTERLEUKIN 2; LATENT MEMBRANE PROTEIN 1; PROMYELOCYTIC LEUKEMIA PROTEIN; PROTEIN KINASE C; PROTEIN P53; RETINOID RELATED ORPHAN RECEPTOR ALPHA; SMAD PROTEIN;

BREAST CANCER; CALCIUM HOMEOSTASIS; CALCIUM SIGNALING; CANCER CELL; CARCINOGENESIS; CELL ACTIVATION; CELL DIFFERENTIATION; CELL GROWTH; CELL IMMORTALIZATION; CELL PROLIFERATION; CELL SURVIVAL; COLON CARCINOMA; ENDOPLASMIC RETICULUM; EPSTEIN BARR VIRUS; FLUOROMETRY; HUMAN; IMMUNOHISTOCHEMISTRY; MYELOID LEUKEMIA; NONHUMAN; PROMYELOCYTIC LEUKEMIA; PROTEIN EXPRESSION; REVIEW; STOMACH CANCER; WESTERN BLOTTING;

EID: 85016352015     PISSN: None     EISSN: 2218273X     Source Type: Journal    
DOI: 10.3390/biom2010165     Document Type: Review

References (137)

1. Bygrave, F.L.; Benedetti, A. What is the concentration of calcium ions in the endoplasmic reticulum? Cell Calcium, 1996, 19, 547-551.
2. Solovyova, N.; Verkhratsky, A. Monitoring of free calcium in the neuronal endoplasmic reticulum: an overview of modern approaches. J. Neurosci. Methods 2002, 122, 1-12.
3. Berridge, M.J. Inositol trisphosphate and calcium signalling mechanisms. Biochim. Biophys. Acta 2009, 1793, 933-940.
4. Laurent-Puig, P.; Lièvre, A.; Blons, H. Mutations and response to epidermal growth factor receptor inhibitors. Clin. Cancer Res. 2009, 15, 1133-1139.
5. de Mello, R.A.; Marques, D.S.; Medeiros, R.; Araujo, A.M. Epidermal growth factor receptor and K-Ras in non-small cell lung cancer-molecular pathways involved and targeted therapies. World J. Clin. Oncol. 2011, 2, 367-376.
6. Feske, S.; Gwack, Y.; Prakriya, M.; Srikanth, S.; Puppel, S.H.; Tanasa, B.; Hogan, P.G.; Lewis, R.S.; Daly, M.; Rao, A. A mutation in Orai1 causes immune deficiency by abrogating CRAC channel function. Nature 2006, 441, 179-185.
7. 2+ entry. Nat. Cell Biol. 2009, 11, 669-677.
8. Barr, V.A.; Bernot, K.M.; Shaffer, M.H.; Burkhardt, J.K.; Samelson, L.E. Formation of STIM and Orai complexes: puncta and distal caps. Immunol. Rev. 2009, 231, 148-159.
9. Petersen, O.H.; Michalak, M.; Verkhratsky, A. Calcium signalling: Past, present and future. Cell Calcium 2005, 38, 161-169.
10. Liu, J.O. Calmodulin-dependent phosphatase, kinases, and transcriptional corepressors involved in T-cell activation. Immunol. Rev. 2009, 228, 184-198.
11. Zhang, S.; Fritz, N.; Ibarra, C.; Uhlen, P. Inositol 1,4,5-trisphosphate receptor subtype-specific regulation of calcium oscillations. Neurochem. Res. 2011, 36, 1175-1185.
12. 2+ signaling systems. Trends Cell Biol. 2011, 21, 202-211.
13. Johnstone, L.S.; Graham, S.J.; Dziadek, M.A. STIM proteins: Integrators of signalling pathways in development, differentiation and disease. J. Cell. Mol. Med. 2010, 14, 1890-1903.
14. 2+ oscillations in pancreatic islets. Bull. Math. Biol. 2008, 70, 1251-1271.
15. Higgins, E.R.; Cannell, M.B.; Sneyd, J. A buffering SERCA pump in models of calcium dynamics. Biophys. J. 2006, 91, 151-163.
16. 2+ uptake by the endoplasmic reticulum. J. Theor. Biol. 2005, 237, 279-290.
17. Juska, A. Calcium fluxes into and out of cytosol in human platelets: Analysis of experimental data. Biochem. Biophys. Res. Commun. 2011, 412, 537-542.
18. Juska, A. Dynamics of calcium fluxes in nonexcitable cells: Mathematical modeling. J. Membr. Biol. 2006, 211,89-99.
19. Juska, A; Redondo, P.C.; Rosado, J.A.; Salido, G.M. Dynamics of calcium fluxes in human platelets assessed in calcium-free medium. Biochem. Biophys. Res. Commun. 2005, 334, 779-786.
20. 2+ buffer in rat basophilic leukemia-1 cells. Biochem. J. 2001, 353, 561-567.
21. 2+ response amplitude and duration. Nature 1997, 386, 855-858.
22. Dolmetsch, R.E.; Xu, K.; Lewis, R.S. Calcium oscillations increase the efficiency and specificity of gene expression. Nature 1998, 392, 933-936.
23. Coe, H.; Michalak, M. Calcium binding chaperones of the endoplasmic reticulum. Gen. Physiol. Biophys. 2009, Focus Issue, 28, F96-F103.
24. Brostrom, M.A.; Brostrom, C.O. Calcium dynamics and endoplasmic reticular function in the regulation of protein synthesis: Implications for cell growth and adaptability. Cell Calcium 2003, 34, 345-363.
25. Burdakov, D.; Petersen, O.H.; Verkhratsky, A. Intraluminal calcium as a primary regulator of endoplasmic reticulum function. Cell Calcium 2005, 38, 303-310.
26. Bedard, K.; Szabó, É.; Michalak, M.; Opas, M. Cellular functions of endoplasmic reticulum chaperones calreticulin, calnexin, and ERp57. Int. Rev. Cytol. 2005, 245, 91-121.
27. Michalak, M.; Groenendyk, J.; Szabó, É.; Gold, L.I.; Opas, M. Calreticulin, a multi-process calcium-buffering chaperone of the endoplasmic reticulum. Biochem. J. 2009, 417, 651-666.
28. Paschen, W. Dependence of vital cell function on endoplasmic reticulum calcium levels: Implications for the mechanisms underlying neuronal cell injury in different pathological states. Cell Calcium 2001, 29, 1-11.
29. Malhotra, J.D.; Kaufman, R.J. The endoplasmic reticulum and the unfolded protein response. Semin. Cell Dev. Biol. 2007, 18, 716-731.
30. Lai, E.; Teodoro, T.; Volchuk, A. Endoplasmic reticulum stress: Signaling the unfolded protein response. Physiology (Bethesda) 2007, 22, 193-201.
31. Mekahli, D.; Bultynck, G.; Parys, J.B.; De Smedt, H.; Missiaen, L. Endoplasmic-reticulum calcium depletion and disease. Cold Spring Harb. Perspect. Biol. 2011, 3, a004317.
32. Høyer-Hansen, M.; Jäättelä, M. Connecting endoplasmic reticulum stress to autophagy by unfolded protein response and calcium. Cell Death Differ. 2007, 14, 1576-1582.
33. Christensen, S.B.; Skytte, D.M.; Denmeade, S.R.; Dionne, C.; Møller, J.V.; Nissen, P.; Isaacs, J.T. A Trojan horse in drug development: Targeting of thapsigargins towards prostate cancer cells. Anticancer Agents Med. Chem. 2009, 9, 276-294.
34. Identifier: NCT 01056029 Dose-Escalation Phase A Study of G-202 in Patients With Advanced Solid Tumors. Available online: http://clinicaltrials.gov (accessed on 04 March 2012).
35. 2+ pumps of the endoplasmic reticulum and Golgi apparatus. Cold Spring Harb. Perspect. Biol. 2011, 3, a004184.
36. 2+-transport ATPases. Chem. Rev. 2009, 109, 4733-4759.
37. Wuytack, F.; Raeymaekers, L.; Missiaen, L. Molecular physiology of the SERCA and SPCA pumps. Cell Calcium 2002, 32, 279-305.
38. 2+ pumps in the brain. Mol. Chem. Neuropathol. 1998, 33, 199-208.
39. 2+ pumps. Biosci. Rep. 1995, 15, 299-306.
40. Gélébart, P.; Martin, V.; Enouf, J.; Papp, B. Identification of a new SERCA2 splice variant regulated during monocytic differentiation. Biochem. Biophys. Res. Commun. 2003, 303, 676-684.
41. 2+ pump. J. Biol. Chem. 1989, 264, 18561-18568.
42. 2+ATPase isoforms are expressed in a cell type? A growing family of membrane proteins illustrated by studies in platelets. Platelets 2005, 16, 133-150.
43. Dally, S.; Corvazier, E.; Bredoux, R.; Bobe, R.; Enouf, J. Multiple and diverse coexpression, location, and regulation of additional SERCA2 and SERCA3 isoforms in nonfailing and failing human heart. J. Mol. Cell. Cardiol. 2010, 48, 633-644.
44. 2+ ATPase (SERCA) catalytic cycle. Biochemistry 2006, 45, 13769-13778.
45. 2+-pump from molecular dynamics simulations. Proc. Natl. Acad. Sci. USA 2010, 107, 21465-21469.
46. Espinoza-Fonseca, L.M.; Thomas, D.D. Atomic-level characterization of the activation mechanism of SERCA by calcium. PLoS One 2011, 6, e26936.
47. Chandrasekera, P.C.; Kargacin, M.E.; Deans, J.P.; Lytton, J. Determination of apparent calcium affinity for endogenously expressed human sarco(endo)plasmic reticulum calcium-ATPase isoform SERCA3. Am. J. Physiol. Cell Physiol. 2009, 296, C1105-C1114.
48. Poch, E.; Leach, S.; Snape, S.; Cacic, T.; MacLennan, D.H.; Lytton, J. Functional characterization of alternatively spliced human SERCA3 transcripts. Am. J. Physiol. 1998, 275, C1449-C1458.
49. 2+-ATPase (SERCA) 1 and 3 isoforms by steady-state and transient kinetic analyses. J. Biol. Chem. 2002. 277, 45579-45591.
50. Periasamy, M.; Kalyanasundaram, A. SERCA pump isoforms: their role in calcium transport and disease. Muscle Nerve 2007, 35, 430-442.
51. Lytton, J.; Westlin, M.; Burk, S.E.; Shull, G.E.; MacLennan, D.H. Functional comparisons between isoforms of the sarcoplasmic or endoplasmic reticulum family of calcium pumps. J. Biol. Chem. 1992, 267, 14483-14489.
52. Papp, B.; Enyedi, A.; Pászty, K, Kovács, T.; Sarkadi, B.; Gárdos, G.; Magnier, C.; Wuytack, F.; Enouf, J. Simultaneous presence of two distinct endoplasmic-reticulum-type calcium-pump isoforms in human cells. Characterization by radio-immunoblotting and inhibition by 2,5-di-(t-butyl)-1,4-benzohydroquinone. Biochem. J. 1992, 288, 297-302.
53. Papp, B.; Enyedi, Á.; Kovács, T.; Sarkadi B.; Wuytack, F.; Thastrup, O.; Gárdos, G.; Bredoux, R.; Lévy-Tolédano, S.; Enouf, J. Demonstration of two forms of calcium pumps by thapsigargin inhibition and radioimmunoblotting in platelet membrane vesicles. J. Biol. Chem. 1991, 266, 14593-14596.
54. 2+-ATPase and inositol 1,4,5-trisphosphate receptor isoforms in vascular endothelial cells. Cell Calcium 1999, 25, 371-380.
55. 2+-ATPase: design of a perfect chemi-osmotic pump. Q. Rev. Biophys. 2010, 43, 501-566.
56. 2+-ATPase 2 (SERCA2) activity: Cell biological implications. Cell Calcium 2005, 38, 291-302.
57. Strehler, E.E.; Treiman, M. Calcium pumps of plasma membrane and cell interior. Curr. Mol. Med. 2004, 4, 323-335.
58. 2+-ATPase pumps ions across the sarcoplasmic reticulum membrane. Biochim. Biophys. Acta 2009, 1793, 941-946.
59. Toyoshima, C. Ion pumping by calcium ATPase of sarcoplasmic reticulum. Adv. Exp. Med. Biol. 2007, 592, 295-303.
60. Brini, M.; Carafoli, E. Calcium pumps in health and disease. Physiol. Rev. 2009, 89, 1341-1378.
61. 2+ ATPase (SERCA) inhibition. J. Bioenerg. Biomembr. 2005, 37, 365-368.
62. Prasad, V.; Okunade, G.W.; Miller, M.L.; Shull, G.E. Phenotypes of SERCA and PMCA knockout mice. Biochem. Biophys. Res. Commun. 2004, 322, 1192-1203.
63. 2+-transporting ATPases. Eur. J. Biochem. 2000, 267, 5284-5290.
64. Hovnanian, A. SERCA pumps and human diseases. Subcell. Biochem. 2007, 45, 337-363.
65. Cooper, S.M.; Burge, S.M. Darier's disease: Epidemiology, pathophysiology, and management. Am. J. Clin. Dermatol. 2003, 4, 97-105.
66. Gommans, I.M.; Vlak, M.H.; de Haan, A.; van Engelen, B.G. Calcium regulation and muscle disease. J. Muscle Res. Cell Motil. 2002, 23, 59-63.
67. 2+ signalling and muscle disease. Eur. J. Biochem. 2000, 267, 5291-5297.
68. 2+ transport. Nat. Rev. Cancer 2007, 7, 519-530.
69. 2+ for cancer cell proliferation and survival. Nat. Rev. Cancer 2008, 8, 361-375.
70. Nasr, R.; de Thé, H. Eradication of acute promyelocytic leukemia-initiating cells by PML/RARA-targeting. Int. J. Hematol. 2010, 91, 742-747.
71. Nasr, R.; Guillemin, M-C.; Ferhi, O.; Soilihi, H.; Peres, L.; Berthier, C.; Rousselot, P.; Robledo-Sarmiento, M.; Lallemand-Breitenbach, V.; Gourmel, B.; Vitoux, D.; Pandolfi, PP.; Rochette-Egly, C.; Zhu, J.; de Thé, H. Eradication of acute promyelocytic leukemia-initiating cells through PML-RARA degradation. Nat. Med. 2008, 14, 1333-1342.
72. Nasr, R.; Lallemand-Breitenbach, V.; Zhu, J.; Guillemin, M-C.; de Thé, H. Therapy-induced PML/RARA proteolysis and acute promyelocytic leukemia cure. Clin. Cancer Res. 2009, 15, 6321-6326.
73. Chomienne, C.; Fenaux, P.; Degos, L. Retinoid differentiation therapy in promyelocytic leukemia. FASEB J. 1996, 10, 1025-1030.
74. Launay, S.; Giannì, M.; Kovács, T.; Bredoux, R.; Bruel, A.; Gélébart, P.; Zassadowski, F.; Chomienne, C.; Enouf, J.; Papp, B. Lineage-specific modulation of calcium pump expression during myeloid differentiation. Blood 1999, 93, 4395-4405.
75. 2+ signalling during megakaryocytic differentiation: An in vitro study. Biochem. J. 2000, 350, 723-734.
76. 2+ATPase isoform 3b and Rap 1b: interrelation and regulation in physiopathology. Biochem. J. 1998, 332, 173-181.
77. Papp, B.; Pászty, K.; Kovács, T.; Sarkadi, B.; Gárdos, G.; Enouf, J.; Enyedi, Á. Characterization of the inositol trisphosphate-sensitive and insensitive calcium stores by selective inhibition of the endoplasmic reticulum-type calcium pump isoforms in isolated platelet membrane vesicles. Cell Calcium 1993, 14, 531-538.
78. Humphries, A.; Wright, N.A. Colonic crypt organization and tumorigenesis. Nat. Rev. Cancer 2008, 8, 415-424.
79. Arends, J.W. Molecular interactions in the Vogelstein model of colorectal carcinoma. J. Pathol. 2000, 190, 412-416.
80. Fearon, E.R.; Vogelstein, B. A genetic model for colorectal tumorigenesis. Cell 1990, 61, 759-767.
81. Bright-Thomas, R.M.; Hargest, R. APC, beta-Catenin and hTCF-4; an unholy trinity in the genesis of colorectal cancer. Eur. J. Surg. Oncol. 2003, 29, 107-117.
82. Aaltonen, L.A.; Hamilton, S.R. Pathology and Genetics of Tumors of the Digestive System; IARC Press: Lyon, France, and Oxford University Press: Oxford, UK, 2000; pp. 1-314.
83. Frazin, G.; Zamboni, G.; Scarpa, A.; Dina, R.; Iannucci, A.; Novelli, P. Hyperplastic (metaplastic) polyps of the colon. A histologic and histochemical study. Am. J. Surg. Pathol. 1984, 8, 687-698.
84. Scholzel, S; Zimmermann, W.; Schwarzkopf, G.; Grunert, F.; Rogaczewski, B.; Thompson, J. Carcinoembryonic antigen family members CEACAM6 and CEACAM7 are differentially expressed in normal tissues and oppositely deregulated in hyperplastic colorectal polyps and early adenomas. Am. J. Pathol. 2000, 156, 595-605.
85. Brouland, J-P.; Gélébart, P.; Kovács, T.; Enouf, J.; Grossmann, J; Papp, B. The loss of sarco/endoplasmic reticulum calcium transport ATPase 3 expression is an early event during the multistep process of colon carcinogenesis. Am. J. Pathol. 2005, 167, 233-242.
86. Gélébart, P.; Kovács, T.; Brouland, J-P.; van Gorp, R.; Grossmann, J.; Rivard, N.; Panis, Y.; Martin, V.; Bredoux, R.; Enouf, J.; Papp, B. Expression of endomembrane calcium pumps in colon and gastric cancer cells. Induction of SERCA3 expression during differentiation. J. Biol. Chem. 2002, 277, 26310-26320.
87. Lipkin, M.; Reddy, B.; Newmark, H.; Lamprecht, S.A. Dietary factors in human colorectal cancer. Annu. Rev. Nutr. 1999, 19, 545-586.
88. Aune, D.; Chan, D.S.; Lau, R.; Vieira, R.; Greenwood, D.C.; Kampman, E.; Norat, T. Dietary fibre, whole grains, and risk of colorectal cancer: Systematic review and dose-response meta-analysis of prospective studies. BMJ 2011, 343, d6617.
89. Artursson, P. Epithelial transport of drugs in cell culture. I: A model for studying the passive diffusion of drugs over intestinal absorptive (Caco-2) cells. J. Pharm. Sci. 1990, 79, 476-482.
90. Reis-Filho, J.S.; Simpson, P.T.; Gale, T.; Lakhani, S.R. The molecular genetics of breast cancer: the contribution of comparative genomic hybridization. Pathol. Res. Pract. 2005, 201, 713-725.
91. Simpson, P.T.; Gale, T.; Reis-Filho, J.S.; Jones, C.; Parry, S.; Sloane, J.P.; Handby, A.; Lee, A.H.; Humphreys, S.; Ellis, IO.; Lakhani S.R. Columnar cell lesions of the breast: the missing link in breast cancer progression? A morphological and molecular analysis. Am. J. Surg. Pathol. 2005, 29, 734-746.
92. Simpson, P.T.; Reis-Filho, J.S.; Gale, T.; Lakhani, S.R. Molecular evolution of breast cancer. J. Pathol. 2005, 205, 248-254.
93. Sørlie, T; Perou, C.M.; Tibshirani, R.; Aas, T.; Geisler, S; Johnsen, H.; Hastie, T.; Eisen, M.B.; van de Rijn, M.; Jeffrey, S.S.; Thorsen, T.; Quist, H.; Matese, J.C.; Brown, P.O.; Botstein, D.; Eystein-Lønning, P.; Børresen-Dale, A.L. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc. Natl. Acad. Sci. USA 2001, 98, 10869-10874.
94. Tavassoli, F.A.; Devilee, P. Pathology and Genetics of Tumors of the Breast and Female Genital Organs; IARC Press: Lyon, France, 2003; pp. 1-432.
95. Perou, C.M.; Borresen-Dale, A.L. Systems biology and genomics of breast cancer. Cold Spring Harb. Perspect. Biol. 2011, 3, a003293.
96. Papp, B.; Brouland, J-P. Altered endoplasmic reticulum calcium pump expression during breast tumorigenesis. Breast Cancer (Auckl) 2011, 5, 163-174.
97. Smith-Garvin, J.E.; Koretzky, G.A.; Jordan, M.S. T cell activation. Annu. Rev. Immunol. 2009, 27, 591-619.
98. Launay, S.; Bobe, R.; Lacabaratz-Porret, C.; Bredoux, R.; Kovács, T.; Enouf, J.; Papp, B. Modulation of endoplasmic reticulum calcium pump expression during T lymphocyte activation. J. Biol. Chem. 1997, 272, 10746-10750.
99. Penninga, L.; Møller, C.H.; Gustafsson, F.; Steinbrüchel, D.A.; Gluud, C. Tacrolimus versus cyclosporine as primary immunosuppression after heart transplantation: Systematic review with meta-analyses and trial sequential analyses of randomised trials. Eur. J. Clin. Pharmacol. 2010, 66, 1177-1187.
100. Bornkamm, G.W.; Hammerschmidt, W. Molecular virology of Epstein-Barr virus. Philos. Trans. R. Soc. Lond. B Biol. Sci. 2001, 356, 437-459.
101. Rowe, D.T. Epstein-Barr virus immortalization and latency. Front. Biosci. 1999, 4, D346-D371.
102. Pattle, S.B.; Farrell, P.J. The role of Epstein-Barr virus in cancer. Expert Opin. Biol. Ther. 2006, 6, 1193-1205.
103. Thompson, M.P.; Kurzrock, R. Epstein-Barr virus and cancer. Clin. Cancer Res. 2004, 10, 803-821.
104. Eliopoulos, A.G.; Young, L.S. LMP-1 structure and signal transduction. Semin. Cancer Biol. 2001, 11, 435-444.
105. Farrell, P.J. Signal transduction from the Epstein-Barr virus LMP-1 transforming protein. Trends Microbiol. 1998, 6, 175-177.
106. Farrell, P.J.; Cludts, I.; Stuhler, A. Epstein-Barr virus genes and cancer cells. Biomed. Pharmacother. 1997, 51, 258-267.
107. Klein, E.; Teramoto, N.; Gogolák, P.; Nagy, N.; Björkholm M. LMP-1, the Epstein-Barr virus-encoded oncogene with a B cell activating mechanism similar to CD40. Immunol. Lett. 1999, 68, 147-154.
108. Wang, D.; Liebowitz, D.; Wang, F.; Gregory, C.; Rickinson, A.; Larson, R.; Springer, T.; Kieff, E. Epstein-Barr virus latent infection membrane protein alters the human B-lymphocyte phenotype: deletion of the amino terminus abolishes activity. J. Virol. 1988, 62, 4173-4184.
109. Lenoir, G.M.; Vuillaume, M.; Bonnardel, C. The use of lymphomatous and lymphoblastoid cell lines in the study of Burkitt's lymphoma. IARC Sci. Publ. 1985, 60, 309-318.
110. Calender, A.; Billaud, M.; Aubry, J-P.; Banchereau, J.; Vuillaume, M.; Lenoir, GM. Epstein-Barr virus (EBV) induces expression of B-cell activation markers on in vitro infection of EBV-negative B-lymphoma cells. Proc. Natl. Acad. Sci. USA 1987, 84, 8060-8064.
111. Wang, F; Tsang, S.F.; Kurilla, M.G.; Cohen, J.I.; Kieff, E. Epstein-Barr virus nuclear antigen 2 transactivates latent membrane protein LMP1. J. Virol. 1990, 64, 3407-3416.
112. Dellis, O.; Arbabian, A.; Brouland, J-P.; Kovács, T.; Rowe, M.; Chomienne, C.; Joab, I.; Papp, B. Modulation of B-cell endoplasmic reticulum calcium homeostasis by Epstein-Barr virus latent membrane protein-1. Mol. Cancer 2009, 8, 59.
113. 2+ signalling. FEBS J. 2009, 276, 1800-1816.
114. 2+ channels: impact on cell function. J. Physiol. 2008, 586, 3043-3054.
115. 2+: Molecular determinants and functional consequences. Physiol. Rev. 2006, 86, 369-408.
116. Chandrasekera, C.P.; Lytton, J. Inhibition of human SERCA3 by PL/IM430. Molecular analysis of the interaction. J. Biol. Chem. 2003, 278, 12482-12488.
117. 2+. Biosci. Rep. 1988, 8, 379-388.
118. Quintana, A.; Pasche, M.; Junker, C.; Al-Ansary, D; Rieger, H.; Kummerow, C.; Nuñez, L.; Villalobos, C.; Meraner, P.; Becherer, U.; Rettig, J.; Niemeyer, BA.; Hoth, M. Calcium microdomains at the immunological synapse: How ORAI channels, mitochondria and calcium pumps generate local calcium signals for efficient T-cell activation. EMBO J. 2011, 30, 3895-3912.
119. Launay, S.; Giannì, M.; Diomede, L.; Machesky, L.M.; Enouf, J.; Papp, B. Enhancement of ATRA-induced cell differentiation by inhibition of calcium accumulation into the endoplasmic reticulum: Cross-talk between RAR alpha and calcium-dependent signaling. Blood 2003, 101, 3220-3228.
120. Apáti, Á.; Jánossy, J.; Brózik, A.; Bauer, PI.; Magócsi, M. Calcium induces cell survival and proliferation through the activation of the MAPK pathway in a human hormone-dependent leukemia cell line, TF-1. J. Biol. Chem. 2003, 278, 9235-9243.
121. Papp, B.; Byrn, R.A. Stimulation of HIV expression by intracellular calcium pump inhibition. J. Biol. Chem. 1995, 270, 10278-10283.
122. Berridge, M.J.; Bootman, M.D.; Roderick, H.L. Calcium signalling: Dynamics, homeostasis and remodelling. Nat. Rev Mol. Cell Biol. 2003, 4, 517-529.
123. 2+ signaling system. Proc. Natl. Acad. Sci. USA 2011, 108, 14485-14490.
124. Tsai, T.Y.; Choi, Y.S.; Ma, W.; Pomerening, J.R.; Tang, C.; Ferrell, J.E. Jr. Robust, tunable biological oscillations from interlinked positive and negative feedback loops. Science 2008, 321, 126-129.
125. 2+ ATPases as dynamic regulators of cellular calcium handling. Ann. NY Acad. Sci. 2007, 1099, 226-236.
126. 2+ pool. Cell Calcium 2010, 48, 143-149.
127. Godic, A.; Strazisar, M.; Zupan, A.; Korosec, B.; Kansky, A.; Glavac, D. Darier disease in Slovenia: Spectrum of ATP2A2 mutations and relation to patients' phenotypes. Eur. J. Dermatol. 2010, 20, 271-275.
128. 2+ pump, cause Darier disease. Nat. Genet. 1999, 21, 271-277.
129. Hakii, H.; Fujiki, H.; Suganuma, M.; Nakayasu, M.; Tahira, T.; Sugimura, T.; Scheuer, P.J.; Christensen, S.B. Thapsigargin, a histamine secretagogue, is a non-12-O-tetradecanoylphorbol-13-acetate (TPA) type tumor promoter in two-stage mouse skin carcinogenesis. J. Cancer Res. Clin. Oncol. 1986, 111, 177-181.
130. Sakai, A.; Teshima, R. 2,5-di-tert-butyl-1,4-hydroquinone enhances cell transformation accompanied by an increase in intracellular free calcium ion concentration. Cancer Lett. 2001, 168, 183-190.
131. Korošec, B.; Glavac, D.; Volavsek, M.; Ravnik-Glavac, M. ATP2A3 gene is involved in cancer susceptibility. Cancer Genet. Cytogenet. 2009, 188, 88-94.
132. 2+ pumps in association with head and neck squamous cell carcinoma. Cancer Genet. Cytogenet. 2008, 181, 112-118.
133. Korošec, B; Glavac, D.; Rott, T.; Ravnik-Glavac, M. Alterations in the ATP2A2 gene in correlation with colon and lung cancer. Cancer Genet. Cytogenet. 2006, 171, 105-111.
134. Juska, A.; Jardin, I.; Rosado, J.A. Physical properties of two types of calcium stores and SERCAs in human platelets. Mol. Cell. Biochem. 2008, 311, 9-18.
135. Means, S.; Smith, A.J.; Shepherd, J.; Shadid, J.; Fowler, J.; Wojcikiewicz, R.J.; Mazel, T.; Smith, G.D.; Wilson, B.S. Reaction diffusion modeling of calcium dynamics with realistic ER geometry. Biophys. J. 2006, 91, 537-557.
136. Aung, C.S.; Ye, W.; Plowman, G.; Peters, A.A.; Monteith, G.R.; Roberts-Thomson, S.J. Plasma membrane calcium ATPase 4 and the remodeling of calcium homeostasis in human colon cancer cells. Carcinogenesis 2009, 30, 1962-1969.
137. 2+ATPase expression during colon and gastric cancer cell differentiation. Cell Calcium 2007, 42, 590-605.